Newsroom
Sorted by: Latest
-
POTTERY BARN KIDS AND POTTERY BARN TEEN UNVEIL TEN HOLIDAY COLLABORATIONS FEATURING ICONIC CHARACTERS, BRANDS AND DESIGNERS
SAN FRANCISCO--(BUSINESS WIRE)--Pottery Barn Kids and Pottery Barn Teen, portfolio brands of Williams-Sonoma, Inc. (NYSE: WSM), the world’s largest digital-first, design-led, and sustainable home retailer, announced the launch of ten new holiday collections designed in partnership with popular collaboration and licensing partners. For more than a decade, Pottery Barn Kids and Pottery Barn Teen have become a leading destination for design-forward collaborations. This holiday season, the brands h...
-
Allotex Five-Year Clinical Results on Its TransForm Human Tissue Platform
BOSTON--(BUSINESS WIRE)--Allotex today announced five-year clinical observations presented in an ESCRS Free Paper by Cafer Tanrıverdi, MD, and collaborators from Medipol University and other clinical institutions in Istanbul. The study evaluated sterile human corneal tissue profiles prepared according to physician-defined geometries and placed in eyes described by the investigators as hyperopic. The ESCRS presentation followed how precision-defined sterile human corneal tissue profiles behaved...
-
Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.
MADRID--(BUSINESS WIRE)--Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager,...
-
NATIXIS UK Regulatory Announcement: Form 8.3 Segro plc
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name o...
-
NATIXIS UK Regulatory Announcement: Form 8.3 Prologis, Inc
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name o...
-
Conduent Completes $447 Million Refinancing, Advancing Deleveraging and De-Risking
FLORHAM PARK, N.J.--(BUSINESS WIRE)--Conduent Incorporated (Nasdaq: CNDT) (“Conduent” or the “Company”), a global technology-enabled operating partner, today announced the successful closing of a comprehensive $447 million refinancing transaction. The transaction extends the Company’s $357 million revolving credit facility through May 2029 and adds $90 million in additional commitments from its existing bank lenders, including a $15 million letter of credit facility, reflecting confidence in th...
-
CRH completes $8.5B acquisition of Arcosa
NEW YORK--(BUSINESS WIRE)--CRH (NYSE: CRH), the leading provider of building materials, today announced that it has completed its acquisition of Arcosa, Inc.CRH previously announced on June 22, 2026 that it had reached an agreement to acquire Arcosa, a leading U.S. provider of aggregates and critical infrastructure products, for a total enterprise value of approximately $8.5 billion.The completed acquisition is highly complementary to CRH, advancing the company’s aggregates-led, connected portfo...
-
XPEL Anuncia Expansão no Brasil com Inauguração de Sede, Centro de Distribuição e Centro de Treinamento em São Paulo
SÃO PAULO--(BUSINESS WIRE)--A XPEL, Inc. (NASDAQ: XPEL), líder global em filmes e revestimentos de proteção, anunciou hoje a inauguração oficial de sua nova sede no Brasil, juntamente com um centro de distribuição e centro de treinamento em São Paulo, marcando um importante marco no compromisso de longo prazo da empresa com um dos maiores e mais dinâmicos mercados automotivos do mundo. Com essa expansão, os revendedores brasileiros passarão a trabalhar diretamente com a XPEL, Inc., obtendo aces...
-
XPEL Announces Expansion into Brazil with Opening of São Paulo Headquarters, Warehouse and Training Center
SÃO PAULO--(BUSINESS WIRE)--XPEL, Inc. (NASDAQ: XPEL), a global leader in protective films and coatings, today announced the official opening of its new Brazil headquarters, warehouse and training center in São Paulo, marking a significant milestone in the company's long-term commitment to one of the world's largest and most dynamic automotive markets. With this expansion, Brazilian dealers will now work directly with XPEL, Inc., providing streamlined access to XPEL's complete portfolio of pain...
-
NATIXIS UK Regulatory Announcement: Form 8.3 Gamma communications plc
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name o...